Improving physical function in older adults with advanced chronic kidney disease
Official title: Enhancing Physical Function in Older Adults With Chronic Kidney Disease (EPIC): A Pilot Randomized Controlled Trial
Run by Wake Forest University Health Sciences · NCT06738394 · Data updated 2026-11-12
We will try a 12-week high-velocity resistance training program to see if it safely improves muscle power and physical function in mobility-limited older adults with advanced chronic kidney disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years to 100 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Status | Recruiting |
| Started | July 31, 2025 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT06738394 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are mobility-limited older adults with stage 3–5 CKD who are not receiving dialysis, can safely perform exercise, are willing to be randomized, and live within about 20 miles of Wake Forest University in Winston-Salem, NC.
✕Probably not a fit
People on dialysis or expected to start dialysis soon, those who are wheelchair-dependent, currently enrolled in resistance training, or with recent/unstable cardiac or orthopedic issues are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot randomized controlled trial will enroll mobility-limited older adults with advanced CKD to compare a 12-week high-velocity resistance training (HVRT) program against an attention control of weekly healthy-lifestyle group sessions. The HVRT group will perform low-load, functional movements performed "as fast as possible" to target muscle power, while the control group receives education and social contact. The trial focuses on feasibility and safety and will collect preliminary outcome data on muscle power and physical function to inform a larger efficacy trial. Participants must be able to exercise safely, not be on dialysis, and attend in-person sessions at Wake Forest in Winston-Salem, NC.
Why it matters
Potential benefit: If successful, HVRT could increase muscle power and improve everyday mobility, helping older adults with CKD maintain independence and reduce disability.
How similar studies have gone: High-velocity resistance training has improved muscle power and function in general older adult populations, but exercise interventions focused on muscle power in CKD patients are scarce and not well tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Chronic kidney disease stages 3-5 * Capacity to complete physical exercise * Lives within 20 miles of Wake Forest Reynolda Campus * Fluent English speaker * Does not plan to travel outside of home area for an extended period of time during study * Willing to be randomized to either intervention group Exclusion Criteria: * Receiving renal replacement therapy (e.g. hemodialysis, peritoneal dialysis) or anticipated to start renal replacement therapy in the next 6 months * Dependent on a wheelchair * Current participation in a resistance training program * Joint replacement or orthopedic surgery in the previous 6 months or planning to have surgery in the next 6 months months * Absolute contraindications to exercise testing according to ACSM: Acute myocardial infarction within the past 6 months Ongoing unstable angina Uncontrolled cardiac arrhythmia with hemodynamic compromise Active endocarditis Symptomatic severe aortic stenosis Decompensated heart failure Acute pulmonary embolism, pulmonary infarction, or deep venous thrombosis Acute myocarditis or pericarditis Acute aortic dissection * Parkinson's disease * Respiratory disease requiring oxygen * Cancer requiring treatment * Currently receiving physical therapy or cardiopulmonary rehabilitation * Type I or insulin dependent Type II Diabetes * Scoring below 32 points on the Telephone Interview for Cognitive Status (TICS) * Site PI/Study Clinician discretion regarding medical status, appropriateness of participation or concern about intervention adherence
Where it's running
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Eliott Arroyo, PhD — Wake Forest University Health Sciences
- Study coordinator: Rodrigo Lion
- Email: epicstudy@wfu.edu
- Phone: 336-758-3784
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Impact of TAVR on kidney function in people with aortic valve disease
This registry tests how trans-catheter aortic valve implantation affects kidney function and the risk of kidney injury in adults with aortic stenosis.
-
Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs
This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.
-
Oral Semaglutide for CKD and MAFLD in adults with diabetes
This study tests whether adding oral semaglutide to standard care can slow kidney and liver disease progression in adults with CKD and MAFLD who have type 2 diabetes.
-
Eye-brain-kidney connections in chronic kidney disease
This study will see if changes in brain network connectivity and retinal blood vessels are linked to cognitive decline and kidney function in adults with chronic kidney disease.
-
Screening for chronic kidney disease
We will see how common chronic kidney disease is among adults followed at a tertiary care center and how many cases were previously undiagnosed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.